Dynavax hep B vaccine shows promise in kidney disease - Reuters PDF Print
ReutersThe vaccine, Heplisav, protected all dialysis and pre-dialysis patients with chronic kidney disease, the company said in a statement. ...Dynavax's Chronic Kidney Disease Study Confirms HEPLISAV's Enhanced

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.